Elizabeth, NJ, United States of America

Dimitar L Filipov

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Schering Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dimitar L Filipov. Retrieved from https://idiyas.com/inventor/dimitar-l-filipov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dimitar L Filipov: Innovator in Pharmaceutical Compounds

Introduction

Dimitar L Filipov is a notable inventor based in Elizabeth, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating obstructive airway diseases. His work exemplifies the intersection of innovation and healthcare.

Latest Patents

Dimitar holds a patent for the "Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound." This invention relates to methods of treating upper and lower obstructive airway diseases using the specified compound. It also includes formulations comprising the compound, as well as polymorphs and processes for synthesizing these polymorphic forms. He has 1 patent to his name.

Career Highlights

Dimitar is currently employed at Schering Corporation, a company known for its focus on innovative pharmaceutical solutions. His role at the company allows him to contribute to the development of new treatments that can improve patient outcomes.

Collaborations

Throughout his career, Dimitar has collaborated with esteemed colleagues, including Pauline C Ting and Joe F Lee. These partnerships have likely enhanced the scope and impact of his research and inventions.

Conclusion

Dimitar L Filipov's work in pharmaceutical innovation highlights the importance of developing effective treatments for obstructive airway diseases. His contributions continue to influence the field and improve healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…